期刊文献+

他克莫司对肾病综合征患者肾功能的影响 被引量:1

Effect of tacrolimus on renal function in patients with nephrotic syndrome
下载PDF
导出
摘要 目的:观察他克莫司药物用于肾病综合征疾病治疗的可行性、有效性。方法:收治肾病综合征患者60例,随机平分为两组。对照组临床使用多巴胺、酚妥拉明治疗,治疗组在此基础上加用他克莫司,对治疗前后患者肾脏损伤指标进行抽血检查,同时对两组疾病治疗效果进行评估。结果:治疗后对照组患者尿蛋白、肾小球滤过率、血清Cys C恢复效果不如治疗组好,P<0.05;对照组症状改善有效率83.3%,低于治疗组的93.3%,P<0.05。结论:临床对肾病综合征患者应用他克莫司治疗,能有效改善患者症状、恢复肾功能。 Objective:To observe the feasibility and effectiveness of tacrolimus in the treatment of nephrotic syndrome.Methods:60patients with nephrotic syndrome were selected.They were randomly divided into the two groups on average.The control group wastreated with dopamine and phentolamine,on this basis,the treatment group was treated with tacrolimus.The indexes of renal injurywere measured before and after treatment,at the same time,the disease treatment effects of the two groups were evaluated.Results:After treatment,the urinary protein,glomerular filtration rate,serum CysC recovery effect of the control group was not good than thetreatment group,P<0.05.The effective rate of symptomatic improvement in the control group was 83.3% lower than that in thetreatment group of 93.3% ,P<0.05.Conclusion:Clinical application of tacrolimus in patients with nephrotic syndrome caneffectively improve the symptoms of patients,restore renal function.
作者 李小莉 Li Xiaoli(Department of Nephrology,the First People's Hospital of Xiangyang City 441000)
出处 《中国社区医师》 2016年第34期60-61,共2页 Chinese Community Doctors
关键词 肾功能 他克莫司 尿蛋白 肾病综合征 Renal function Tacrolimus Urinary protein Nephrotic syndrome
  • 相关文献

参考文献8

二级参考文献51

  • 1ZHAOHong-yang SUNRuo-peng DONGJun-hua ZHENJun-hui.Relations of nuclear factor-kappa B activity in the kidney of children with primary nephrotic syndrome to clinical manifestations, pathological types, and urinary protein excretion[J].Chinese Medical Journal,2005(10):854-856. 被引量:5
  • 2沈淑琼,黎磊石,胡伟新,刘志红.普乐可复诱导治疗弥漫增生性狼疮性肾炎疗效的影响因素分析[J].肾脏病与透析肾移植杂志,2005,14(3):201-207. 被引量:8
  • 3乔丽,张耀全,程悦,袁发焕.激素抵抗肾病综合征患者血清IL-1β和TNF-α的变化及意义[J].重庆医学,2006,35(23):2153-2154. 被引量:8
  • 4Westhoff TH, van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome [ J] . Expert Opin Investig Drugs, 2007, 16 (7): 1099-1110.
  • 5Habashy D, Hodson EM, Craig JC. Interventions for steroid-resistant nephrotic syndrome: a systematic re- view [J]. Pediatr Nephrol, 2003, 18 (9) : 906-912.
  • 6Loeffler K, Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome [J] . Pediatr Nephrol, 2004, 19 (3): 281- 287.
  • 7Kusunoki Y, Tanaka N, Kaneko K, et al. Taerolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study [J]. Mod Rheumatol, 2009,19 (6) :616-621.
  • 8Lee Y H, Woo J H, Choi S J, et al. Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials [J]. Scand J Rheumatol, 2010,39(4) :271-278.
  • 9Li X, Li H, Ye H, et al. Tacrolimus therapy in adults with steroid-and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR [J]. Am J Kidney Dis, 2009, 54(1) :51-58.
  • 10Chen W, Liu Q, Liao Y, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephmtic syndrome: a prospective, multieenter clinical trial [J]. Am J Med Sci, 2013,345 (2) :81-87.

共引文献154

同被引文献35

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部